rs11537578
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000530340.6(FHL2):c.120C>T(p.Cys40=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00207 in 1,614,124 control chromosomes in the GnomAD database, including 67 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 37 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 30 hom. )
Consequence
FHL2
ENST00000530340.6 synonymous
ENST00000530340.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0990
Genes affected
FHL2 (HGNC:3703): (four and a half LIM domains 2) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. This protein is thought to have a role in the assembly of extracellular membranes. Also, this gene is down-regulated during transformation of normal myoblasts to rhabdomyosarcoma cells and the encoded protein may function as a link between presenilin-2 and an intracellular signaling pathway. Multiple alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 2-105386397-G-A is Benign according to our data. Variant chr2-105386397-G-A is described in ClinVar as [Benign]. Clinvar id is 48320.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-105386397-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.099 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.011 (1677/152266) while in subpopulation AFR AF= 0.0386 (1602/41544). AF 95% confidence interval is 0.037. There are 37 homozygotes in gnomad4. There are 817 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1677 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHL2 | NM_001318895.3 | c.120C>T | p.Cys40= | synonymous_variant | 3/7 | ENST00000530340.6 | NP_001305824.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHL2 | ENST00000530340.6 | c.120C>T | p.Cys40= | synonymous_variant | 3/7 | 1 | NM_001318895.3 | ENSP00000433567 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0110 AC: 1676AN: 152148Hom.: 36 Cov.: 32
GnomAD3 genomes
AF:
AC:
1676
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00287 AC: 721AN: 251340Hom.: 16 AF XY: 0.00194 AC XY: 264AN XY: 135836
GnomAD3 exomes
AF:
AC:
721
AN:
251340
Hom.:
AF XY:
AC XY:
264
AN XY:
135836
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00114 AC: 1665AN: 1461858Hom.: 30 Cov.: 31 AF XY: 0.000920 AC XY: 669AN XY: 727230
GnomAD4 exome
AF:
AC:
1665
AN:
1461858
Hom.:
Cov.:
31
AF XY:
AC XY:
669
AN XY:
727230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0110 AC: 1677AN: 152266Hom.: 37 Cov.: 32 AF XY: 0.0110 AC XY: 817AN XY: 74462
GnomAD4 genome
AF:
AC:
1677
AN:
152266
Hom.:
Cov.:
32
AF XY:
AC XY:
817
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 17, 2012 | Cys40Cys in exon 2 of FHL2: This variant is not expected to have clinical signif icance as it does not lead to an amino acid change and has been observed in 3.8% (142/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS). - |
Primary dilated cardiomyopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at